Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Ward

Showing results (391-400 of 481) with videos related to

Pageof 49
Sort By:
Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.
Science (New York, N.Y.)|July 24, 2025
De novo-designed pMHC binders facilitate T cell-mediated cytotoxicity toward cancer cellsKristoffer Haurum Johansen, Darian Stephan Wolff, Beatrice Scapolo, et al.
Immunity|August 20, 2022
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responsesJeroen M J Tas, Ja-Hyun Koo, Ying-Cing Lin, et al.
Plant Biotechnology Journal|November 20, 2024
Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacySteven W de Taeye, Loïc Faye, Bertrand Morel, et al.
The Journal of Biological Chemistry|July 6, 2026
Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerasesSimon M Walker, Arlo J Loutan, Egor P Tchesnokov, et al.
Nature Communications|August 3, 2022
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoproteinJelle van Schooten, Elinaz Farokhi, Anna Schorcht, et al.
Cell Reports|July 8, 2021
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.
Plos Pathogens|October 3, 2024
Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopesMitch Brinkkemper, Gius Kerster, Philip J M Brouwer, et al.
Nature|September 5, 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interfaceJinghe Huang, Byong H Kang, Marie Pancera, et al.
Immunity|October 23, 2020
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza VirusesJenna J Guthmiller, Linda Yu-Ling Lan, Monica L Fernández-Quintero, et al.
Pageof 49

Showing results (391-400 of 481) with videos related to

Sort By:
Pageof 49
Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.
Science (New York, N.Y.)|July 24, 2025
De novo-designed pMHC binders facilitate T cell-mediated cytotoxicity toward cancer cellsKristoffer Haurum Johansen, Darian Stephan Wolff, Beatrice Scapolo, et al.
Immunity|August 20, 2022
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responsesJeroen M J Tas, Ja-Hyun Koo, Ying-Cing Lin, et al.
Plant Biotechnology Journal|November 20, 2024
Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacySteven W de Taeye, Loïc Faye, Bertrand Morel, et al.
The Journal of Biological Chemistry|July 6, 2026
Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerasesSimon M Walker, Arlo J Loutan, Egor P Tchesnokov, et al.
Nature Communications|August 3, 2022
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoproteinJelle van Schooten, Elinaz Farokhi, Anna Schorcht, et al.
Cell Reports|July 8, 2021
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.
Plos Pathogens|October 3, 2024
Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopesMitch Brinkkemper, Gius Kerster, Philip J M Brouwer, et al.
Nature|September 5, 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interfaceJinghe Huang, Byong H Kang, Marie Pancera, et al.
Immunity|October 23, 2020
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza VirusesJenna J Guthmiller, Linda Yu-Ling Lan, Monica L Fernández-Quintero, et al.
Pageof 49